CA2879834A1 - Highly diverse combinatorial antibody libraries - Google Patents

Highly diverse combinatorial antibody libraries Download PDF

Info

Publication number
CA2879834A1
CA2879834A1 CA2879834A CA2879834A CA2879834A1 CA 2879834 A1 CA2879834 A1 CA 2879834A1 CA 2879834 A CA2879834 A CA 2879834A CA 2879834 A CA2879834 A CA 2879834A CA 2879834 A1 CA2879834 A1 CA 2879834A1
Authority
CA
Canada
Prior art keywords
antibody
library
human
families
lambda
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2879834A
Other languages
English (en)
French (fr)
Inventor
Johannes Joseph Wilhelmus De Haard
Christophe Frederic Jerome Blanchetot
Alex KLARENBEEK
Ikbel ACHOUR
Khalil EL MAZOUARI
Jurgen DEL FAVERO
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ArgenX BVBA
Original Assignee
ArgenX SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ArgenX SE filed Critical ArgenX SE
Publication of CA2879834A1 publication Critical patent/CA2879834A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/461—Igs containing Ig-regions, -domains or -residues form different species
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/005—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies constructed by phage libraries
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/22—Immunoglobulins specific features characterized by taxonomic origin from camelids, e.g. camel, llama or dromedary
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
CA2879834A 2012-08-31 2013-09-02 Highly diverse combinatorial antibody libraries Abandoned CA2879834A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261695819P 2012-08-31 2012-08-31
US61/695,819 2012-08-31
PCT/EP2013/068110 WO2014033304A2 (en) 2012-08-31 2013-09-02 Highly diverse combinatorial antibody libraries

Publications (1)

Publication Number Publication Date
CA2879834A1 true CA2879834A1 (en) 2014-03-06

Family

ID=49117845

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2879834A Abandoned CA2879834A1 (en) 2012-08-31 2013-09-02 Highly diverse combinatorial antibody libraries

Country Status (9)

Country Link
US (1) US10040870B2 (enExample)
EP (1) EP2890709A2 (enExample)
JP (1) JP6283030B2 (enExample)
CN (1) CN104583236A (enExample)
AU (1) AU2013310839B2 (enExample)
CA (1) CA2879834A1 (enExample)
IL (1) IL236524B (enExample)
IN (1) IN2015DN00138A (enExample)
WO (1) WO2014033304A2 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9708412B2 (en) 2015-05-21 2017-07-18 Harpoon Therapeutics, Inc. Trispecific binding proteins and methods of use
WO2017201493A1 (en) 2016-05-20 2017-11-23 Harpoon Therapeutics, Inc. Single chain variable fragment cd3 binding proteins
EP3493844A4 (en) 2016-05-20 2021-03-24 Harpoon Therapeutics Inc. SINGLE DOMAIN SERUM ALBUMIN BINDING PROTEIN
US11623958B2 (en) 2016-05-20 2023-04-11 Harpoon Therapeutics, Inc. Single chain variable fragment CD3 binding proteins
WO2018007999A1 (en) 2016-07-08 2018-01-11 Staten Biotechnology B.V. Anti-apoc3 antibodies and methods of use thereof
AU2017363300A1 (en) 2016-11-23 2019-06-20 Harpoon Therapeutics, Inc. Prostate specific membrane antigen binding protein
WO2018098356A1 (en) * 2016-11-23 2018-05-31 Harpoon Therapeutics, Inc. Psma targeting trispecific proteins and methods of use
WO2018103093A1 (zh) * 2016-12-09 2018-06-14 深圳华大基因研究院 骆驼科抗体可变区免疫组库构建的引物组合及应用
US11535668B2 (en) 2017-02-28 2022-12-27 Harpoon Therapeutics, Inc. Inducible monovalent antigen binding protein
CN110506056A (zh) 2017-04-21 2019-11-26 斯塔滕生物技术有限公司 抗apoc3抗体和其使用方法
WO2018209304A1 (en) 2017-05-12 2018-11-15 Harpoon Therapeutics, Inc. Msln targeting trispecific proteins and methods of use
EP3621994A4 (en) 2017-05-12 2020-12-30 Harpoon Therapeutics, Inc. MESOTHELIN BINDING PROTEINS
MX2020003915A (es) 2017-10-13 2020-10-08 Harpoon Therapeutics Inc Proteinas trispecificas y metodos de uso.
IL315737A (en) 2017-10-13 2024-11-01 Harpoon Therapeutics Inc B-cell maturation antigen-binding proteins
PE20210119A1 (es) 2017-10-31 2021-01-19 Staten Biotechnology B V Anticuerpos anti-apoc3 y metodos de uso de estos
BR112020023330A2 (pt) 2018-05-14 2021-04-20 Harpoon Therapeutics, Inc. porção de ligação para ativação condicional de moléculas de imunoglobulina
US12195544B2 (en) 2018-09-21 2025-01-14 Harpoon Therapeutics, Inc. EGFR binding proteins and methods of use
US10815311B2 (en) 2018-09-25 2020-10-27 Harpoon Therapeutics, Inc. DLL3 binding proteins and methods of use
AU2020275002A1 (en) 2019-05-14 2021-12-23 Harpoon Therapeutics, Inc. EpCAM binding proteins and methods of use
CN115768463A (zh) 2020-02-21 2023-03-07 哈普恩治疗公司 Flt3结合蛋白及使用方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9722131D0 (en) 1997-10-20 1997-12-17 Medical Res Council Method
US8444976B2 (en) * 2008-07-02 2013-05-21 Argen-X B.V. Antigen binding polypeptides
GB2461546B (en) * 2008-07-02 2010-07-07 Argen X Bv Antigen binding polypeptides
CN102459591B (zh) * 2009-05-20 2015-05-13 诺维莫尼公司 合成性的多肽文库以及用于建立具有天然多样性的多肽变体的方法
GB2476681B (en) 2010-01-04 2012-04-04 Argen X Bv Humanized camelid VH, VK and VL immunoglobulin domains

Also Published As

Publication number Publication date
CN104583236A (zh) 2015-04-29
AU2013310839B2 (en) 2017-06-01
IN2015DN00138A (enExample) 2015-06-12
WO2014033304A2 (en) 2014-03-06
JP6283030B2 (ja) 2018-02-21
IL236524A0 (en) 2015-02-26
JP2015526495A (ja) 2015-09-10
WO2014033304A3 (en) 2014-05-01
IL236524B (en) 2019-01-31
AU2013310839A1 (en) 2015-01-29
US20150166680A1 (en) 2015-06-18
EP2890709A2 (en) 2015-07-08
US10040870B2 (en) 2018-08-07

Similar Documents

Publication Publication Date Title
AU2013310839B2 (en) Highly diverse combinatorial antibody libraries
Zhang Evolution of phage display libraries for therapeutic antibody discovery
Georgiou et al. The promise and challenge of high-throughput sequencing of the antibody repertoire
Glanville et al. Precise determination of the diversity of a combinatorial antibody library gives insight into the human immunoglobulin repertoire
D’Angelo et al. Many routes to an antibody heavy-chain CDR3: necessary, yet insufficient, for specific binding
Parola et al. Integrating high‐throughput screening and sequencing for monoclonal antibody discovery and engineering
JP4791960B2 (ja) ルックスルー突然変異誘発
US20190263936A1 (en) Method for mass humanization of non-human antibodies
Mathonet et al. The application of next generation sequencing to the understanding of antibody repertoires
Tu et al. Landscape of variable domain of heavy‐chain‐only antibody repertoire from alpaca
Erasmus et al. A single donor is sufficient to produce a highly functional in vitro antibody library
Kim et al. Deep sequencing of B cell receptor repertoire
Teixeira et al. Simultaneous affinity maturation and developability enhancement using natural liability-free CDRs
Burton Monoclonal antibodies from combinatorial libraries
Schardt et al. Monoclonal Antibody Generation Using Single B Cell Screening for Treating Infectious Diseases: JS Schardt et al.
Gallo The rise of big data: deep sequencing-driven computational methods are transforming the landscape of synthetic antibody design
Larsen et al. Next‐generation approaches to advancing eco‐immunogenomic research in critically endangered primates
JP6665274B2 (ja) 標的分子に結合するポリペプチドの決定方法及び決定システム
Pabst et al. Old questions, new tools: does next-generation sequencing hold the key to unraveling intestinal B-cell responses?
Sun et al. Degenerate primer design to clone the human repertoire of immunoglobulin heavy chain variable regions
Ford Uncovering the hidden diversity of antibody heavy chains and their implications for autoantibody mediated disease.
WO2025098470A1 (en) Natural and artificial intelligent methods for discovering humanlike nanobodies with low immunogenicity
WO2026055339A1 (en) Methods for identifying cognate immunoglobulin pairs from individual b cells
유덕균 Prediction of antigen binding reactivity using supervised learning on clonal enrichment pattern through bio-panning
Fahad In-Depth Functional Interrogation of Paired Antibody and T Cell Immune Repertoires

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20180816

FZDE Discontinued

Effective date: 20200831